6533b7d5fe1ef96bd12650e2
RESEARCH PRODUCT
Tissue microenvironment dictates the fate and tumor-suppressive function of type 3 ILCs
Sara H. BurkhardIsabel OhsChristoph S.n. KloseSebastian J. ArnoldKathrin NussbaumAndreas DiefenbachFlorian MairBurkhard BecherSonia Tuguessubject
0301 basic medicinemedicine.medical_treatmentImmunology314610 Medicine & healthBiology10263 Institute of Experimental ImmunologyArticle31103 medical and health sciencesMiceRAR-related orphan receptor gammaCell Line TumormedicineImmunology and AllergyAnimalsLymphocytesskin and connective tissue diseasesTranscription factorResearch ArticlesMice Knockout2403 ImmunologyInnate lymphoid cellNeoplasms ExperimentalNuclear Receptor Subfamily 1 Group F Member 3PhenotypeCell biologybody regionsKiller Cells NaturalMice Inbred C57BL030104 developmental biologyCytokineCellular MicroenvironmentCell cultureTumor progressionInterleukin 122723 Immunology and AllergyCytokines570 Life sciences; biologyTranscription Factorsdescription
Nussbaum et al. found that tumor suppression through innate lymphoid cells (ILCs) cannot be predicted solely based on the ILC phenotype and lineage but that their immune properties are shaped both by their ontogeny and by the tissue microenvironment they reside in.
year | journal | country | edition | language |
---|---|---|---|---|
2017-01-01 |